<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05080634</url>
  </required_header>
  <id_info>
    <org_study_id>22042020</org_study_id>
    <nct_id>NCT05080634</nct_id>
  </id_info>
  <brief_title>Analysis of Prevalence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy</brief_title>
  <official_title>Analysis of Incidence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maria Sklodowska-Curie Institute - Oncology Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maria Sklodowska-Curie Institute - Oncology Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Achalasia is an uncommon disorder that results from the degeneration of ganglion cells of the&#xD;
      myenteric plexus in the lower esophageal wall. Peroral endoscopic myotomy (POEM) is a&#xD;
      minimally invasive procedure capable of overcoming limitations of achalasia treatments. This&#xD;
      study aimed to: 1) identify the prevalence of reflux esophagitis and asymptomatic GERD in&#xD;
      patients who underwent POEM, and 2) evaluate patient and intraprocedural variables associated&#xD;
      with post-POEM GERD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>The prevalence of gastroesophageal reflux after peroral endoscopic myotomy (POEM)</measure>
    <time_frame>36 Months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Achalasia</condition>
  <condition>GERD</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patients who underwent POEM</intervention_name>
    <description>chalasia patients were recruited from a single center. The pre- and postoperative assessments included Eckardt scores, GerdQ questionnaire, high-resolution esophageal manometry, esophagogastroscopy and pH monitoring.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients treated at a single center who had a complete GERD evaluation after POEM will&#xD;
        be included in the study. Demographics, preoperative and follow-up data, results of&#xD;
        functional studies and procedural data will be collected and analyzed.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Males and females who are 18 years of age and older and are willing to sign an&#xD;
             Informed Consent Form (ICF)&#xD;
&#xD;
          2. Achalasia patients who underwent POEM&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Lack of written consent for participation in the study&#xD;
&#xD;
          2. Conditions which are contraindication to Esophagogastroscopy and High-resolution&#xD;
             Esophageal Manometry&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Chaber-Ciopińska, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Maria Sklodowska-Curie National Research Institute of Oncology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Chaber-Ciopińska, PhD</last_name>
    <phone>(+48) 225463044</phone>
    <email>annachaber@op.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aleksandra Budnicka-Borkowicz, MD</last_name>
    <phone>(+48) 791000890</phone>
    <email>aleksandra.budnicka-borkowicz@coi.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maria Sklodowska-Curie Institute - Oncology Center</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Chaber-Ciopińska, PhD</last_name>
      <phone>+48 225463044</phone>
      <email>annachaber@op.pl</email>
    </contact>
    <contact_backup>
      <last_name>Aleksandra Budnicka-Borkowicz, MD</last_name>
      <phone>+48 791000890</phone>
      <email>aleksandra.budnicka-borkowicz@coi.pl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 4, 2021</study_first_submitted>
  <study_first_submitted_qc>October 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peroral endoscopic myotomy</keyword>
  <keyword>High-resolution esophageal manometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Esophagitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

